Start with RUO controls
Before reviewing a catalog, confirm the supplier operates with explicit Research Use Only controls. The listing should clearly exclude human and veterinary use and should map policy language to checkout attestation.
Strong RUO controls reduce downstream compliance risk and make procurement reviews easier for institutions and labs.
Verify peptide identity and lot traceability
Prioritize sequence-level metadata, CAS references where available, lot identifiers, and linked Certificate of Analysis records. These fields are the baseline for repeatable, auditable lab workflows.
If a catalog entry cannot connect a product to a lot-level verification trail, treat that as an acquisition risk.
Evaluate evidence labels, not hype
A credible research catalog separates mechanistic, preclinical, and controlled outcomes evidence. That hierarchy keeps interpretation disciplined and reduces claim inflation.
Use dossier links and source references to validate whether a claim is supported by the cited study type.